SightAtlasUK
A free UK resource

Everything you need,
in one place.

Clear, accessible information for people living with sight conditions — and the people who support them.

May 2026 · Reviewed monthly

Something not quite right?

💛 Why this site exists

When my daughter was diagnosed with Stargardts, I had so many questions. I couldn't find anywhere that had everything in one place.

Find your condition

Search 17 eye conditions — get research, practical guides, benefits help & support

Type your condition then tap Search (or press Enter)

Just diagnosed?

Start here.

You don't need to figure everything out today. Here are five things that actually matter in the first weeks.

Recent Updates May 2026
Research

Stargardt: SpliceBio's dual-vector ABCA4 gene therapy (SB-007) has treated its first patient in the ASTRA Phase 1/2 trial at Oxford. AAVantgarde Bio's CELESTE trial is also recruiting adults with ABCA4 mutations.

Research

Retinitis Pigmentosa: MeiraGTx RPGR gene therapy Phase 2/3 trial reports significant preservation of visual field in X-linked RP patients at 12-month follow-up.

Research

Usher Syndrome: ProQR's antisense oligonucleotide therapy for USH2A (QR-421a) shows continued visual function preservation at 24 months in ongoing trial.

Benefits

PIP & DLA rates updated May 2026 (3.8% rise): Daily Living enhanced rate £114.60/week. Mobility enhanced rate £80.00/week. Attendance Allowance higher rate £114.60/week. Carer's Allowance £86.45/week.

Technology

All conditions: Apple iOS 18 introduced significant VoiceOver improvements including enhanced image descriptions and improved braille display support.

Henshaws Knowledge Village — Featured Resource

Free video training specifically for people with sight loss — how to use an iPhone if you can't see the screen, Android accessibility, screen readers, and practical technology skills. The best free tech training resource in the UK for people with sight loss.

Visit Henshaws Knowledge Village ↗

Helpful YouTube Channels

Note: External links. Sight Atlas is not responsible for their content. Always discuss medical information with your ophthalmologist.